Evidence for reduced dentate gyrus and fimbria volume in bipolar II disorder

Bipolar Disorders

Volumn 15, Issue 2, 2013, Pages 167-176

  Elvsåshagen, Torbjørn ^a,b   Westlye, Lars T ^a,b   Bøen, Erlend ^a,b   Hol, Per K ^a   Andersson, Stein ^a   Andreassen, Ole A ^a,b   Boye, Birgitte ^a   Malt, Ulrik F ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Bipolar II disorder; Dentate gyrus; Fimbria; Hippocampus; Neurogenesis

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NITRAZEPAM; OXAZEPAM; QUETIAPINE; SERTRALINE; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; BIPOLAR II DISORDER; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DENTATE HILUS; FEMALE; HIPPOCAMPAL FIMBRIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NERVE PROJECTION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STRESS; WHITE MATTER;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DENTATE GYRUS; FEMALE; FORNIX, BRAIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; YOUNG ADULT;

EID: 84874237566     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12046     Document Type: Article

References (54)

1. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-151.
2. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edn. New York: Oxford University Press, 2007.
3. Angst J, Cui L, Swendsen J et al.Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry 2010; 167: 1194-1201.
4. Benazzi F. Bipolar disorder - focus on bipolar II disorder and mixed depression. Lancet 2007; 369: 935-945.
5. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123C: 48-58.
6. Huang J, Perlis RH, Lee PH et al.Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 2010; 167: 1254-1263.
7. Eriksson PS, Perfilieva E, Bjork-Eriksson T et al.Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313-1317.
8. Ming GL, Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011; 70: 687-702.
9. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008; 132: 645-660.
10. Airan RD, Meltzer LA, Roy M, Gong Y, Chen H, Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007; 317: 819-823.
11. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007; 10: 1110-1115.
12. Santarelli L, Saxe M, Gross C et al.Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-809.
13. Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011; 476: 458-461.
14. Schloesser RJ, Manji HK, Martinowich K. Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response. NeuroReport 2009; 20: 553-557.
15. Surget A, Tanti A, Leonardo ED et al.Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 2011; 16: 1177-1188.
16. Jankord R, Herman JP. Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 2008; 1148: 64-73.
17. Herman JP, Schafer MK, Young EA et al.Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 1989; 9: 3072-3082.
18. Radley JJ, Sawchenko PE. A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response. J Neurosci 2011; 31: 9683-9695.
19. Duvernoy H. The Human Hippocampus. Functional Anatomy, Vascularization and Serial Sections with MRI. New York: Springer-Verlag, 2005.
20. Andersen P, Morris R, Amaral D, Bliss T, O'Keefe J. The Hippocampus Book. New York: Oxford University Press, 2007.
21. Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Res 1992; 592: 228-238.
22. Sapolsky RM, Armanini MP, Sutton SW, Plotsky PM. Elevation of hypophysial portal concentrations of adrenocorticotropin secretagogues after fornix transection. Endocrinology 1989; 125: 2881-2887.
23. Gold SM, Kern KC, O'Connor MF et al.Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry 2010; 68: 553-559.
24. Barnea-Goraly N, Chang KD, Karchemskiy A, Howe ME, Reiss AL. Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis. Biol Psychiatry 2009; 66: 238-244.
25. Van Leemput K, Bakkour A, Benner T et al.Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 2009; 19: 549-557.
26. Teicher MH, Anderson CM, Polcari A. Childhood maltreatment is associated with reduced volume in the hippocampal subfields CA3, dentate gyrus, and subiculum. Proc Natl Acad Sci USA 2012; 109: E563-E572.
27. Sheehan DV, Lecrubier Y, Sheehan KH et al.The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20): 22-33.
28. Suppes T, Leverich GS, Keck PE et al.The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001; 67: 45-59.
29. Drake R, Mueser K, McHugo G. Clinical rating scales: Alcohol Use Scale (AUS), Drug Use Scale (DUS), and Substance Abuse Treatment Scale (SAYS). In: Sederer L, Dickey B eds. Outcomes Assessment in Clinical Practice. Baltimore: Williams & Wilkins, 1996: 113-116.
30. Bernstein DP, Fink L, Handelsman L et al.Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 1994; 151: 1132-1136.
31. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
32. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
33. Fischl B, Salat DH, Busa E et al.Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-355.
34. Fischl B, Salat DH, van der Kouwe AJ et al.Sequence-independent segmentation of magnetic resonance images. NeuroImage 2004; 23 (Suppl. 1): S69-S84.
35. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65: 1017-1032.
36. Bora E, Fornito A, Yucel M, Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 2010; 67: 1097-1105.
37. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009; 195: 194-201.
38. Hallahan B, Newell J, Soares JC et al.Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry 2011; 69: 326-335.
39. Bearden CE, Thompson PM, Dutton RA et al.Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology 2008; 33: 1229-1238.
40. Schloesser RJ, Martinowich K, Manji HK. Mood-stabilizing drugs: mechanisms of action. Trends Neurosci 2012; 35: 36-46.
41. Jacobs BL, Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000; 5: 262-269.
42. Petrik D, Lagace DC, Eisch AJ. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?Neuropharmacology 2012; 62: 21-34.
43. Manganas LN, Zhang X, Li Y et al.Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 2007; 318: 980-985.
44. Rueger MA, Backes H, Walberer M et al.Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J Neurosci 2010; 30: 6454-6460.
45. Xu J, Rasmussen IA, Berntsen EM et al.A growth in bipolar disorder?Acta Psychiatr Scand 2007; 115: 246-250.
46. Bratt AM, Kelley SP, Knowles JP et al.Long term modulation of the HPA axis by the hippocampus. Behavioral, biochemical and immunological endpoints in rats exposed to chronic mild stress. Psychoneuroendocrinology 2001; 26: 121-145.
47. Conrad CD. Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci 2008; 19: 395-411.
48. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000; 886: 172-189.
49. Bremner JD, Randall P, Vermetten E et al.Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report. Biol Psychiatry 1997; 41: 23-32.
50. Karl A, Werner A. The use of proton magnetic resonance spectroscopy in PTSD research--meta-analyses of findings and methodological review. Neurosci Biobehav Rev 2010; 34: 7-22.
51. Vythilingam M, Heim C, Newport J et al.Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002; 159: 2072-2080.
52. Stein MB, Koverola C, Hanna C, Torchia MG, McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 1997; 27: 951-959.
53. Schloesser RJ, Huang J, Klein PS, Manji HK. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008; 33: 110-133.
54. Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 2000; 5: 578-593.